AU2665899A - Use of anti-cd44 monoclonal antibody to enhance wound healing - Google Patents
Use of anti-cd44 monoclonal antibody to enhance wound healingInfo
- Publication number
- AU2665899A AU2665899A AU26658/99A AU2665899A AU2665899A AU 2665899 A AU2665899 A AU 2665899A AU 26658/99 A AU26658/99 A AU 26658/99A AU 2665899 A AU2665899 A AU 2665899A AU 2665899 A AU2665899 A AU 2665899A
- Authority
- AU
- Australia
- Prior art keywords
- monoclonal antibody
- wound healing
- enhance wound
- enhance
- healing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2565698A | 1998-02-18 | 1998-02-18 | |
US09025656 | 1998-02-18 | ||
PCT/US1999/002775 WO1999042132A1 (en) | 1998-02-18 | 1999-02-10 | Use of anti-cd44 monoclonal antibody to enhance wound healing |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2665899A true AU2665899A (en) | 1999-09-06 |
Family
ID=21827322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26658/99A Abandoned AU2665899A (en) | 1998-02-18 | 1999-02-10 | Use of anti-cd44 monoclonal antibody to enhance wound healing |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2665899A (en) |
WO (1) | WO1999042132A1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5587301A (en) * | 1995-03-10 | 1996-12-24 | Incyte Pharmaceuticals, Inc. | DNA encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells |
-
1999
- 1999-02-10 WO PCT/US1999/002775 patent/WO1999042132A1/en active Application Filing
- 1999-02-10 AU AU26658/99A patent/AU2665899A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999042132A1 (en) | 1999-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1462300A (en) | Human pan-hcv human monoclonal antibodies | |
AU1704099A (en) | Monoclonal human natural antibodies | |
PL349266A1 (en) | Human monoclonal antibodies to ctla-4 | |
AU4042195A (en) | Anti-alphaV-integrin monoclonal antibody | |
IL130864A0 (en) | Monoclonal antibodies to human cd6 | |
WO1999062526A3 (en) | Use of genetically engineered antibodies to cd38 to treat multiple myeloma | |
AU5674696A (en) | Compounds that bind to p185 and methods of using the same | |
AU5141193A (en) | Monoclonal antibodies to prostate cells | |
EE200000470A (en) | Human anti-CD40 antibodies | |
AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
AU2573595A (en) | Antibodies which bind to insect gut proteins and their use | |
AU5365296A (en) | Human monoclonal antibody against lung carcinoma | |
AU2001218871A1 (en) | Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same | |
AU2001256325A1 (en) | Human and humanized fap-alpha-specific antibodies | |
AU5686698A (en) | Methods for the production of chicken monoclonal antibodies | |
HUP0101151A3 (en) | Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbetha6-integrin attachment to fibnronectin | |
AU7676300A (en) | Human anti-adipocyte monoclonal antibodies and their use | |
AU5441000A (en) | Human monoclonal antibody | |
AU6702998A (en) | Anti-alphabeta3 humanized monoclonal antibodies | |
NO975581D0 (en) | Steps to reduce bone loss | |
AU6155896A (en) | Humanized antibodies to e-selectin | |
AU3483395A (en) | A monoclonal antibody to human cardiac troponin i | |
DE59610754D1 (en) | SIMPLIFIED MANUFACTURE OF SPECIFIC ANTIBODY FRAGMENTS | |
HUP9800613A3 (en) | Humanized antibody against human fas-antigene | |
EP0977590A4 (en) | Human monoclonal antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |